Logo

Indegene Share Price

Indegene (INR)614.9-14.1   (-2.2%)

Exchange ScripsBSE544172NSEINDGNISININE065X01017

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Indegene Performance

Market performance
Open price629.45
High631.4
Volumes849068
Prev Close614.9
Low604.45
Closing date2025-01-10
Historical performance
1 Year High736.30
3 Year High736.30
5 Year High736.30
1 Year Low470.10
3 Year Low470.10
5 Year Low470.10

Indegene Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
14727
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
40.54
Dividend Yield
Dividend Yield
N/A

Indegene Investment Returns

1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A

Indegene Technicals

IndicatorsValueSignal
5-DMA617.56Bearish
10-DMA609.76Bullish
20-DMA601.5Bullish
50-DMA628.91Bearish
100-DMA640.72Bearish
200-DMA

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024
Promoters---------
Foreign Investors---------
Domestic Investors---------
Public Investors151440203599443785
Government---------

Indegene Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income763582259306
Operating Profit5817454131282612
Interest4943136070
Depreciation761598335255
Profit Before Tax4586363022652315
Consolidated Net Profit3367266116481494
Adjusted EPS151278

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital44444343
Total Reserves135331001775783198
Minority Interest---------86
Total Non-Current Liabilities43485839800268
Total Liabilities2474821368128435593
Capital Work in Progress------------
Total Assets2474821368128435593

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities5077130229701720
Cash Flow from Investing Activities-3272-8933-1602-242
Cash Flow from Financing Activitie-66233312335-1315
Net Cash Inflow / Outflow1143-43003703163
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 40.54.
  • 3Y Stock Price CAGR of the stock is None.
  • The stock has a beta of 0.9.
  • In the last financial year, the company had an EBITDA of ₹5817 Million.
  • The company generated revenue of ₹25896 Million in the previous financial year.

Indegene

614.9-14.1   (-2.2%)

Investment Amount: ₹ 57090
Current Value: ₹ 61490
Performance: 7.7%
P/L: ₹ 4400
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
JAICORPLTD173(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month